GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 218 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $15,000 | +114.3% | 214 | 0.0% | 0.00% | – |
Q2 2022 | $7,000 | 0.0% | 214 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | +16.7% | 214 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | +20.0% | 214 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +25.0% | 214 | +84.5% | 0.00% | – |
Q2 2021 | $4,000 | -20.0% | 116 | 0.0% | 0.00% | – |
Q1 2021 | $5,000 | 0.0% | 116 | 0.0% | 0.00% | – |
Q4 2020 | $5,000 | -73.7% | 116 | -66.7% | 0.00% | – |
Q3 2020 | $19,000 | +11.8% | 348 | +2.4% | 0.00% | – |
Q2 2020 | $17,000 | 0.0% | 340 | 0.0% | 0.00% | – |
Q1 2020 | $17,000 | -37.0% | 340 | 0.0% | 0.00% | – |
Q4 2019 | $27,000 | +42.1% | 340 | -11.0% | 0.00% | – |
Q3 2019 | $19,000 | 0.0% | 382 | +6.7% | 0.00% | – |
Q2 2019 | $19,000 | 0.0% | 358 | 0.0% | 0.00% | – |
Q1 2019 | $19,000 | +90.0% | 358 | +48.5% | 0.00% | – |
Q4 2018 | $10,000 | +11.1% | 241 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | -18.2% | 241 | 0.0% | 0.00% | – |
Q2 2018 | $11,000 | -8.3% | 241 | 0.0% | 0.00% | – |
Q1 2018 | $12,000 | – | 241 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |